U.S. may not reach COVID-19 herd immunity until Thanksgiving, Biden officials reportedly say
Members of President Biden's COVID-19 team are telling officials the U.S. may not achieve COVID-19 herd immunity until Thanksgiving or early winter, two senior administration officials tell The Daily Beast.
Vaccine distribution is lagging across the U.S. and uncertainty surrounds whether the shots are reaching underserved populations hit hardest by the virus. And while the Moderna and Pfizer vaccines are still effective against the highly transmissible coronavirus variants identified so far, evidence suggests they may be less so. The yet-to-be-approved one-shot Johnson & Johnson vaccine has also proved less effective against the newer variants. Scientists are also concerned about the emergence of more strains in the next few months that may be more resistant to vaccines and immunity attained by previous coronavirus infections, The Washington Post reports.
The reported warning comes after Biden indicated earlier this week that it'll be "very difficult" to reach herd immunity before the end of the summer with the current vaccine distribution rate of 1.3 million shots given each day.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Kathryn is a graduate of Syracuse University, with degrees in magazine journalism and information technology, along with hours to earn another degree after working at SU's independent paper The Daily Orange. She's currently recovering from a horse addiction while living in New York City, and likes to share her extremely dry sense of humor on Twitter.
-
Quiz of The Week: 15 – 21 NovemberQuiz Have you been paying attention to The Week’s news?
-
Can the UK do more on climate change?Today's Big Question Labour has shown leadership in the face of fraying international consensus, but must show the public their green mission is ‘a net benefit, not a net cost’
-
The Week Unwrapped: Will US Catholics rebel against the Pope?Podcast Plus what are the ethics of freezing your late partner?
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
